Literature DB >> 12573307

Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.

J Melke1, L Westberg, M Landén, C Sundblad, O Eriksson, F Baghei, R Rosmond, E Eriksson, A Ekman.   

Abstract

The purpose of this study was to investigate if women with premenstrual dysphoria differ from controls with respect to the number of platelet serotonin transporters, and with respect to three polymorphisms in the gene coding for the serotonin transporter: a 44 base pair insertion/deletion in the promoter region, a variable number of tandem repeats in the second intron, and a single nucleotide polymorphism in the 3' untranslated region. Also, the possible relationship between the three polymorphisms and platelet serotonin transporter density was analyzed. The density of platelet [(3)H]paroxetine binding sites was significantly lower in women with premenstrual dysphoria than in controls, but patients and controls did not differ with respect to allele or genotype frequency for any of the three polymorphisms examined. A significant association between the number of platelet serotonin transporters and the promoter polymorphism was observed, subjects being homozygous for the short (deletion) variant having higher platelet serotonin transporter density than subjects carrying the long (insertion) allele. The results support the assumption that serotonin-related psychiatric disorders-such as premenstrual dysphoria-may be associated with a reduction in platelet [(3)H]paroxetine binding, but argue against the notion that this reduction is due to certain variants of the serotonin transporter gene being more common in patients than in controls.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573307     DOI: 10.1016/s0306-4530(02)00033-1

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  10 in total

1.  Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls.

Authors:  Alexandra Miller; Hoa Vo; Liang Huo; Catherine Roca; Peter J Schmidt; David R Rubinow
Journal:  J Psychiatr Res       Date:  2010-02-20       Impact factor: 4.791

Review 2.  Reproductive Affective Disorders: a Review of the Genetic Evidence for Premenstrual Dysphoric Disorder and Postpartum Depression.

Authors:  Katherine McEvoy; Lauren M Osborne; Julie Nanavati; Jennifer L Payne
Journal:  Curr Psychiatry Rep       Date:  2017-10-30       Impact factor: 5.285

3.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

4.  The 5-HTTLPR polymorphism, platelet serotonin transporter activity and platelet serotonin content in underweight and weight-recovered females with anorexia nervosa.

Authors:  Stefan Ehrlich; Leonora Franke; Susann Scherag; Roland Burghardt; Regina Schott; Nora Schneider; Simone Brockhaus; Jakob Hein; Ralf Uebelhack; Ulrike Lehmkuhl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-03       Impact factor: 5.270

5.  Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.

Authors:  Liang Huo; Richard E Straub; Catherine Roca; Peter J Schmidt; Kai Shi; Radhakrishna Vakkalanka; Daniel R Weinberger; David R Rubinow
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

Review 6.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

7.  Premenstrual syndrome.

Authors:  Kimberly Ann Yonkers; P M Shaughn O'Brien; Elias Eriksson
Journal:  Lancet       Date:  2008-04-05       Impact factor: 79.321

Review 8.  Core symptoms of major depressive disorder: relevance to diagnosis and treatment.

Authors:  Sidney H Kennedy
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

9.  Effect of serotonin reuptake inhibitors on pulmonary hemodynamics in humans.

Authors:  Hilde Pleym; Guri Greiff; Tom Mjorndal; Roar Stenseth; Alexander Wahba; Olav Spigset
Journal:  J Clin Med Res       Date:  2011-09-26

10.  Temporomandibular disorder is associated with a serotonin transporter gene polymorphism in the Japanese population.

Authors:  Kiyomi Ojima; Nagaoki Watanabe; Naoko Narita; Masaaki Narita
Journal:  Biopsychosoc Med       Date:  2007-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.